CENTESSA PHARMACEUTICALS PLC ADS overview
CENTESSA PHARMACEUTICALS PLC ADS
> News
GlobeNewsWire published a news.
Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
•
•
GlobeNewsWire •
Stocks •
More CENTESSA PHARMACEUTICALS PLC ADS news...
Thank you
Chart
CENTESSA PHARMACEUTICALS PLC ADS
> News
GlobeNewsWire published a news.
Centessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at American Society of Hematology (ASH) Annual Meeting
•
•
GlobeNewsWire •
Stocks •
More CENTESSA PHARMACEUTICALS PLC ADS news...
Thank you
Chart
Statistics
- Analyses : 0
- Followers : 0